Market Snapshot

BSE Sensex: 83576.24 -0.72%
BSE 500: 36807.62 -0.89%
BSE 200: 11620.53 -0.79%
BSE 100: 26904.82 -0.73%
BSE MidCap: 46304.8 -0.90%
BSE SmallCap: 49912.11 -1.74%
BSE BANKEX: 66616.92 -0.58%
BSE IT: 36795.24 0.03%
Nifty 50: 25683.3 -0.75%
Nifty 500: 23467.35 -0.90%
Nifty 200: 14306.95 -0.79%
Nifty 100: 26252.95 -0.79%
Nifty Midcap 100: 59748.15 -0.79%
Nifty Small 100: 17282.65 -1.81%
Nifty IT: 38027.2 0.28%
Nifty PSU Bank: 8601.05 0.18%

News:

Protean eGov Technologies bags...
PTC Industries? arm secures ma...
Globus Spirits reports multi-f...
IREDA Q3 PAT jumps 15% YoY to ...
Tejas Networks reports dismal ...

Strides Pharma Science Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

09 Jan 2026 | 04:14 PM

941.85

-26.15 (-2.70%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

42.94%

Return (1Y)

Beaten Nifty 50 by 33.78%
More Volatile

3%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.27%
Consistent Performer

7/12

Months

beaten Nifty 50
AxisDirect View

No View

52 Week High-Low

1,025

513

News & Announcements

Strides Pharma slides as US arm receives 4 USFDA observations for New York facility
17 days ago

Strides Pharma slides as US arm receives 4 USFDA observations for New York facility

26 - Dec - 2025 12:00 | 17 days ago

In an exchange filing, the company said the current Good Manufacturing Practices (cGMP) inspection was conducted by the US Food and Drug Administration (USFDA) at the facility between 17 December and 23 December 2025. At the conclusion of the inspection, the regulator issued a Form 483 containing four observations.
The company clarified that the observations are procedural in nature and are not expected to have any impact on the supply of its commercial products. SPI will submit a comprehensive response to the USFDA within the stipulated timeframe and expressed confidence in addressing all the observations to the regulator?s satisfaction.
Strides Pharma further stated that it will keep the stock exchanges informed of any further developments in this matter. The official announcement was made on 24 December 2025, after market hours.
Strides Pharma Science is a global pharmaceutical company headquartered in Bangalore, India. It develops and manufactures a wide range of niche and technically complex pharmaceutical products.
The company?s consolidated net profit jumped 81.98% to Rs 131.52 crore on a 4.62% increase in revenue from operations to Rs 1,220.83 crore in Q2 Sept 2025 over Q2 Sept 2024.
Powered by Capital Market - Live News
Strides Pharma Science announces change in senior management
40 days ago

Strides Pharma Science announces change in senior management

03 - Dec - 2025 12:00 | 40 days ago

Strides Pharma Science announced that Puneet Kumar Malik, Senior Management Personnel of the Company has desired to relinquish his position w.e.f. close of business hours on 31 January 2026 to pursue other opportunity within the Aditya Birla Group.
Powered by Capital Market - Live News
Strides Pharma Science announces resignation of Group CHRO
40 days ago

Strides Pharma Science announces resignation of Group CHRO

03 - Dec - 2025 12:00 | 40 days ago

Strides Pharma Science announced that Surabhi Loshali, Group CHRO of the Company, has resigned from Strides to pursue her personal and professional aspirations. Her last working day with Strides shall be closing business hours of 02 January 2026.
Powered by Capital Market - Live News
Strides Pharma Science consolidated net profit rises 77.52% in the September 2025 quarter
73 days ago

Strides Pharma Science consolidated net profit rises 77.52% in the September 2025 quarter

31 - Oct - 2025 12:00 | 73 days ago

Net profit of Strides Pharma Science rose 77.52% to Rs 127.53 crore in the quarter ended September 2025 as against Rs 71.84 crore during the previous quarter ended September 2024. Sales rose 4.62% to Rs 1220.83 crore in the quarter ended September 2025 as against Rs 1166.93 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 1220.83 1166.93 5

OPM % 18.88 15.76 -

PBDT 211.53 138.53 53

PBT 161.89 90.08 80

NP 127.53 71.84 78

Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

MF shareholding in Strides Shasun Ltd has decreased by -3.96% since past 3 Months
FII shareholding in Strides Shasun Ltd has decreased by -5.21% since past 1 Year
MF shareholding in Strides Shasun Ltd has decreased by -21.53% since past 1 Year
Promoter shareholding in Strides Shasun Ltd has increased by 7.83% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1220.83	1166.93	5
OPM %	18.88	15.76	-
PBDT	211.53	138.53	53
PBT	161.89	90.08	80
NP	127.53	71.84	78

General Notifications

My Notifications

Research Notifications

Strides Pharma Science Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

941.85 -26.15 (-2.70%)

News & Announcements

Price vs Volume

Stock Trivia

Strides Pharma Science Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

941.85

-26.15 (-2.70%)